Helena Cowley, MS, MBA
Chief executive officer

As the CEO, Ms. Cowley drives action with a solid scientific understanding and a result oriented focus. She holds a Master’s degree in Bioengineering and a MBA degree from the University of Florida. 

Ms. Cowley started her career as a Research Engineer at Volvo Car Corporation, which followed by various research functions related to medical devices, and enzyme therapeutics. 

Her research has resulted in two pending patents and she has been instrumental in Captozyme’s proof-of-principle in vivo studies and the receipt of five SBIR grants.


Qing-shan Li, PhD
Chief Scientific officer

Dr. Qing-Shan Li is a co-founder and CSO of Captozyme. Qing-Shan graduated from East China University of Science and Technology in 1994 with a PhD in Biochemical Engineering. 

From 1998 to 2001, he held post-doctoral research positions at Kyoto University and Stuttgart University. He subsequently entered into a Research Scientist position at the University of Kansas under the direction of Professor’s Robert Hanzlick and Robert Borchardt (2001-2005). 

In 2005, Qing-Shan joined OxThera Inc. (Alachua, FL) where he continued to reside as a R&D Director until establishing Captozyme.


Aaron Cowley, PhD, MBA
Chief operating officer

As the co-founder and COO, Dr. Cowley strives to build Captozyme into a renowned player in the biotech community. He holds a Bachelor’s (Biochemistry), PhD (Inorganic Chemistry) and MBA degree from Benedictine College, University of Kansas and the University of Florida, respectively. 

He was the recipient of the prestigious Ruth L. Kirschstein National Research Service award for his post-doctoral work at the University of Georgia, and his work has culminated in 15 peer reviewed journal articles. 

Dr. Cowley was a Scientist II/Preclinical Manager at OxThera Inc. (Alachua, FL) prior to establishing Captozyme in 2009.